← New search
Phenotype profile

lung cancer

SaudiVarKB evidence summary derived from retained literature mentions.

299Phenotype mentions
100Publications
50Associated gene records
50Associated variant records

Associated gene records

Co-mentioned in the same publications
GeneIdentifier / contextArticlesMentions
EGFRHGNC:32366767
KRASHGNC:64071717
ALKHGNC:4271616
ROS1HGNC:102611010
STAT3HGNC:1136488
BRAFHGNC:109766
PTENHGNC:958844
ESR1HGNC:346744
PIK3CAHGNC:897544
APCHGNC:58344
TNFHGNC:1189233
CSHGNC:242233
TP53HGNC:1199833
BAXHGNC:95933
NEAT1HGNC:3081533
CDK2HGNC:177133
XRCC1HGNC:1282833
RETHGNC:996722
NLRP3HGNC:1640022
SOD1HGNC:1117922
PPARGHGNC:923622
IL6HGNC:601822
BCL2HGNC:99022
PTGS2HGNC:960522
BRCA1HGNC:110022
CD44HGNC:168122
SMAD4HGNC:677022
HSP90AA1HGNC:525322
CCL2HGNC:1061822
CDH1HGNC:174822
CDKN2AHGNC:178722
EZH2HGNC:352722
CASP3HGNC:150422
HIF1AHGNC:491022
NRASHGNC:798922
PRMT5HGNC:1089422
CXCR4HGNC:256122
PVT1HGNC:970922
HRASHGNC:517322
ERBB2HGNC:343022
AURKBHGNC:1139022
CD4HGNC:167811
PAHHGNC:858211
CDK4HGNC:177311
ZEB1HGNC:1164211
CD40HGNC:1191911
TBX4HGNC:1160311
ARHGNC:64411
TGHGNC:1176411
CYP2D6HGNC:262511

Associated variant records

Co-mentioned in the same publications
VariantIdentifier / contextArticlesMentions
T790MT790M55
T790MT790M44
C797SC797S33
L858RL858R33
C797SC797S22
rs1800629rs180062911
R721GR721G11
A756DA756D11
Y791CY791C11
E734KE734K11
E805KE805K11
F893LF893L11
R897QR897Q11
R897GR897G11
R912QR912Q11
R912GR912G11
M918TM918T11
p.Met918Thrp.Met918Thr11
p.Arg897Glnp.Arg897Gln11
rs4950928rs495092811
C712RC712R11
rs193922722rs19392272211
Q633LQ633L11
rs2144684101rs214468410111
C255GC255G11
rs1242097924rs124209792411
D55GD55G11
rs2044414353rs204441435311
G12CG12C11
rs361525rs36152511
rs3804099rs380409911
rs3804100rs380410011
G12DG12D11
rs822336rs82233611
rs2297136rs229713611
rs4143815rs414381511
G12CG12C11
C118TC118T11
G2032RG2032R11
D2033ND2033N11
I1039TI1039T11
rs1799793rs179979311
rs13181rs1318111
rs25487rs2548711
rs861539rs86153911
rs1801131rs180113111
T1232AT1232A11
p.Glu709Xp.Glu709X11
p.Gly719Xp.Gly719X11
p.Ser768Ilep.Ser768Ile11

Associated population records

Co-mentioned in the same publications
PopulationIdentifier / contextArticlesMentions
Saudi Arabia22
Population recordCohort 6522
Population recordCohort 622
Population recordCohort 4122
Population recordCohort 2011
Population recordCohort 311
Population recordCohort 11411
Population recordCohort 95011
Population recordCohort 2411
Population recordCohort 1911
Population recordCohort 111
Population recordCohort 4011
Population recordCohort 211
Population recordCohort 10011
Population recordCohort 6111
Population recordCohort 19611
Population recordCohort 20011
Population recordCohort 3011
Population recordCohort 3311
Saudi Arabia · HailCohort 111
Population recordCohort 14111
Population recordCohort 4811
Population recordCohort 4511
Population recordCohort 6411
Population recordCohort 93911
Population recordCohort 9311
Population recordCohort 7111
Saudi ArabiaCohort 13411
Population recordCohort 10111
Population recordCohort 2,01611
Population recordCohort 24011
Population recordCohort 12611
Saudi Arabia · RiyadhCohort 1811
Population recordCohort 4911
Population recordCohort 6,23611
Population recordCohort 22511
Saudi ArabiaCohort 70811
Saudi Arabia · MadinahCohort 6511
Population recordCohort 3,63911
Saudi Arabia · NajranCohort 4411
Population recordCohort 83111
Population recordCohort 85111
Population recordCohort 82011
Population recordCohort 79911
Population recordCohort 27211
Population recordCohort 4,29511
Population recordCohort 3,96611
Saudi ArabiaCohort 23011
Population recordCohort 70211
Population recordCohort 2,04411

Supporting publications

100 records
  1. 2026Comparative anti-cancer properties of carene isoforms induced apoptotic cell death in stomach and lung cancer cell lines.Naunyn-Schmiedeberg's archives of pharmacology1 mentions
  2. 2026CRISPR-Edited Cell Lines: A New Era in Functional Oncology Research.Current pharmaceutical design1 mentions
  3. 2026KRASG12D/G13D-USP15 axis promotes TGF-β/SMAD signaling and glycolytic flux to accelerate NSCLC pathogenesis.Lung cancer (Amsterdam, Netherlands)1 mentions
  4. 2026Pharmacophore-guided review of EGFR-targeted anticancer drugs with gefitinib as a reference.European journal of medicinal chemistry1 mentions
  5. 2026Real-world adoption of off-label combinations for targeted therapy resistance in non-small cell lung cancer.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico1 mentions
  6. 2026Chitosan-functionalized mesoporous silica nanoparticles co-loaded with chrysin and quercetin: a potent strategy against lung cancer cells.Scientific reports1 mentions
  7. 2026Exploring structural diversity and dynamic stability of small-molecule PRMT5 inhibitors through machine learning-based QSAR and molecular modelling.Molecular diversity1 mentions
  8. 2026Integrating multiomics data using a correlation based graph attention network for subtype classification in lower grade glioma.Discover oncology1 mentions
  9. 2026The role of microRNAs in modulating Wnt signaling pathway dynamics and their therapeutic implications in non-small cell lung cancer.Discover oncology1 mentions
  10. 2026Clinical validation of lightweight CNN architectures for reliable multi-class classification of lung cancer using histopathological imaging techniques.Scientific reports1 mentions
  11. 2026Profound alterations of cancer transcriptomes by the RNase L inhibitor ABCE1 through the modulation of UU/UA-dinucleotide rich transcript abundance.RNA biology1 mentions
  12. 2026Identifying regulatory driver motifs in non-small cell lung carcinoma via a systematic approach.PloS one1 mentions
  13. 2026Transcriptomic and multi-layer variant analysis identifies STAT3 and HIF1A as central regulators of regulated cell death pathways in lung squamous cell carcinoma.Naunyn-Schmiedeberg's archives of pharmacology1 mentions
  14. 2026Smoking-dependent circulating non-coding biomarkers in lung cancer.Clinica chimica acta; international journal of clinical chemistry1 mentions
  15. 2026Molecular Docking and MD Modeling Techniques for the Development of Novel ROS1 Kinase Inhibitors.Pharmaceuticals (Basel, Switzerland)1 mentions
  16. 2026Reprogramming resistance in advanced lung cancer: epigenetic modulation to restore therapeutic vulnerability.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico1 mentions
  17. 2026The global cancer crisis: a review of growing burden, deepening inequality and initiatives for prevention and early detection.Ecancermedicalscience1 mentions
  18. 2026Medicinal Chemistry of Fourth-generation Tyrosine Kinase Inhibitors.Mini reviews in medicinal chemistry1 mentions
  19. 2026Explainable deep learning-based lung cancer diagnosis using clinically-guided local interpretable model-agnostic explanations.Scientific reports1 mentions
  20. 2026A multi-stage computational pipeline for repurposing FDA-approved drugs: application to EGFR C797S-mutant NSCLC.Frontiers in chemistry1 mentions
  21. 2026Green-synthesized CdTe quantum dots: dual-action nanomaterials tackling antimicrobial resistance and cancer.RSC advances1 mentions
  22. 2026Decoding Prognostic Signatures in Brain Metastatic Non-Small-Cell Lung Cancer via Integrated Multi-Omics and Network Analysis.International journal of molecular sciences1 mentions
  23. 2026Evaluating the ability of generative AI to standardize TNM staging data in lung cancer.Seminars in oncology1 mentions
  24. 2026Functional and mechanistic inactivation of immune hubs orchestrates tumor development and progression in lung adenocarcinoma.Discover oncology1 mentions
  25. 2026Circulating CHI3L1/YKL-40 in lung cancer: Biomarker potential, analytical challenges, and clinical translation prospects.Clinica chimica acta; international journal of clinical chemistry1 mentions
  26. 2026Efficient Estimation Methods for the QR Distribution with Type-II Censored Data: An Empirical Validation on Lung Cancer Prognosis.Entropy (Basel, Switzerland)1 mentions
  27. 2026Exploring hypoxia-related genes as prognostic indicators in lung adenocarcinoma.PloS one1 mentions
  28. 2026Immune Landscape and Tumour Heterogeneity in Ovarian Cancer: Insights From Single-Cell RNA Sequencing.Journal of cellular and molecular medicine1 mentions
  29. 2026Evaluation of PD-L1 Expression and Systemic Inflammatory Blood Cell Ratios as Prognosticators in Advanced Lung, Breast and Head and Neck Cancers.Cancers1 mentions
  30. 2026Synthesis and multilevel evaluation of benzimidazole-based anticancer compounds: DNA/serum albumin interaction, and in-depth theoretical insights.Molecular and cellular biochemistry1 mentions
  31. 2026Germline variants and impact on lung cancer outcomes following chemotherapy: A systematic review.Critical reviews in oncology/hematology1 mentions
  32. 2026From Mechanisms to Therapeutic Innovation in Non-Small Cell Lung Cancer: A Knowledge-Depth Translational Mapping with Experimental Validation.International journal of molecular sciences1 mentions
  33. 2026Modeling the Effects of Single Nucleotide Polymorphisms (SNPs) on the Structure and Function of the Human RET Gene: An In Silico Study.Human mutation1 mentions
  34. 2026Identification of selective N-pyridinsulfonyl indole based thiosemicarbazone derivatives as potential antiproliferative agents against lung cancer cells.RSC advances1 mentions
  35. 2026Heptapharmacological activity of Quercetin-3-O-phosphate against lung cancer pathways.PloS one1 mentions
  36. 2025The use of Isoflavones as Lung Cancer Chemoprevention Agents and their Implications in Treatment through Radio Sensitization.Current medicinal chemistry1 mentions
  37. 2025The implication of microbiome in lungs cancer: mechanisms and strategies of cancer growth, diagnosis and therapy.Critical reviews in microbiology1 mentions
  38. 2025Investigating the chemo-preventive role of noscapine in lung carcinoma via therapeutic targeting of human aurora kinase B.Molecular and cellular biochemistry1 mentions
  39. 2025Immunotherapy plus Chemotherapy for Patients with EGFR-Mutated Non-Squamous Cell Lung Cancer for Disease Progression after EGFR Tyrosine-Kinase Inhibitor: A Meta-Analysis of Randomized Controlled Trials.Oncology1 mentions
  40. 2025Investigating the antioxidant and anticancer potential of Daucus spp. extracts against human prostate cancer cell line C4-2, and lung cancer cell line A549.Journal of ethnopharmacology1 mentions
  41. 2025Exosomal ncRNAs in liquid biopsies for lung cancer.Clinica chimica acta; international journal of clinical chemistry1 mentions
  42. 2025Unraveling the Ferroptosis-inducing Potential of Methanol Leaves Extract of Prosopis Juliflora Via Downregulation of SLC7A11 and GPX4 mRNA Expression in A549 Lung Cancer Cells.Current medicinal chemistry1 mentions
  43. 2025Comprehensive analysis and outcomes of hybridization of physiologically active heterocycles targeting epidermal growth factor receptor (EGFR).Computers in biology and medicine1 mentions
  44. 2025Reprogramming tumor-associated macrophages: The role of MEK-STAT3 inhibition in lung cancer.Pathology, research and practice1 mentions
  45. 2025Betanin inspired zinc oxide nanoparticles: The potential antioxidant and anticancer activity against human lung cancer cell line (A549).Biochemical and biophysical research communications1 mentions
  46. 2025Unveiling the mechanism of sericin and hydroxychloroquine in suppressing lung oxidative impairment and early carcinogenesis in diethylnitrosamine-induced mice by modulating PI3K/Akt/Nrf2/NF-κB signaling pathway.Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie1 mentions
  47. 2025Liquid mosquito repellent induces toxic effects in zebrafish.Drug and chemical toxicology1 mentions
  48. 2025Epidermal growth factor receptors unveiled: a comprehensive survey on mutations, clinical insights of global inhibitors, and emergence of heterocyclic derivatives as EGFR inhibitors.Journal of drug targeting1 mentions
  49. 2025Cellular plasticity and non-small cell lung cancer: role of T and NK cell immune evasion and acquisition of resistance to immunotherapies.Cancer metastasis reviews1 mentions
  50. 2025Molecular mechanisms of phytoconstituents from selected Egyptian plants against non-small cell lung cancer using integrated in vitro network pharmacology and molecular docking approach.Naunyn-Schmiedeberg's archives of pharmacology1 mentions
  51. 2025The incidence of venous thromboembolism by type of solid cancer worldwide: A systematic review.Cancer epidemiology1 mentions
  52. 2025A Computational Recognition Analysis of Promising Prognostic Biomarkers in Breast, Colon and Lung Cancer Patients.International journal of molecular sciences1 mentions
  53. 2025Deciphering the anticancer potential of thymoquinone: in-depth exploration of the potent flavonoid from Nigella sativa.Molecular biology reports1 mentions
  54. 2025miR-210: A non-invasive biomarker for hypoxia-driven lung cancer diagnosis and therapy.Clinica chimica acta; international journal of clinical chemistry1 mentions
  55. 2025An innovative approach to development of new pyrazolylquinolin-2-one hybrids as dual EGFR and BRAFV600E inhibitors.Molecular diversity1 mentions
  56. 2025Leveraging deep learning for epigenetic protein prediction: a novel approach for early lung cancer diagnosis and drug discovery.Health information science and systems1 mentions
  57. 2025Tumor-educated platelets in lung cancer.Clinica chimica acta; international journal of clinical chemistry1 mentions
  58. 2025Targeting KRAS-G12C in lung cancer: The emerging role of PROTACs in overcoming resistance.Pathology, research and practice1 mentions
  59. 2025The role of Wnt/β-catenin signaling in lung cancer progression and therapy: a comprehensive review.Medical oncology (Northwood, London, England)1 mentions
  60. 2025Electric-Field Molecular Fingerprinting to Probe Cancer.ACS central science1 mentions
  61. 2025Marine-Inspired Spirooxindole PIM-1 Kinase Inhibitors Endowed with Concomitant TRKA/CDK2 Inhibition for Multifaceted Non-Small Cell Lung Cancer Apoptotic Induction.ChemMedChem1 mentions
  62. 2025Cigarette smoke modulates methylation levels of LEF1-AS1 and impedes its expression: An experimental study.Tobacco induced diseases1 mentions
  63. 2025Exploring the Profiles of ROS1 Tyrosine Kinase: A Structural Analysis of G2032R and D2033N Mutations.International journal of applied & basic medical research1 mentions
  64. 2025Design and Synthesis of New pyrazole Hybrids Linked to Oxime and Nitrate Moieties as COX-2, EGFRL858R/T790M Inhibitors and Nitric Oxide Donors with dual Anti-inflammatory/Anti-proliferative Activities.Bioorganic chemistry1 mentions
  65. 2025Synthesis of Marine-Inspired Multifaceted DNA Damaging Spirooxindoles Combating NSCLC and Associated Bacterial Infection.ACS medicinal chemistry letters1 mentions
  66. 2025In vivo and in vitro therapeutic evaluation of bone marrow-derived mesenchymal stem cells in liver cancer treatment.Frontiers in cell and developmental biology1 mentions
  67. 2025Rare aggressive presentation of primary cutaneous diffuse large B-Cell lymphoma, leg type, in the upper arm with concurrent non-small cell lung cancer.BMJ case reports1 mentions
  68. 2025Unlocking the Molecular Targets in Non-Small-Cell Lung Cancer and a Nanomedicine-Based Remedy.Critical reviews in therapeutic drug carrier systems1 mentions
  69. 2025An overview of lncRNA GAPLINC's role in human cancer growth and metastasis.Archives of biochemistry and biophysics1 mentions
  70. 2025Cadherin family genes in non-small cell lung cancer: implications for diagnosis, prognosis, and targeted therapy.American journal of translational research1 mentions
  71. 2025In vitro antioxidant, anticholinesterase, and antiproliferative activities of methanol extracts of Crateva religiosa bark.Journal of Cancer1 mentions
  72. 2025From EGFR mutations to STAT30-driven resistance in NSCLC: Biomarkers and multi-modal treatment approach.Pathology, research and practice1 mentions
  73. 2025Endocrine manifestations of lung adenocarcinoma with epidermal growth factor receptor mutation mimicking tuberculosis: A case report and literature review.Qatar medical journal1 mentions
  74. 2025Triazole-functionalized benzofuran and benzothiophene semicarbazides as novel VEGFR-2-targeted anti-cancer agents.Bioorganic chemistry1 mentions
  75. 2025Optimized deep learning approach for lung cancer detection using flying fox optimization and bidirectional generative adversarial networks.PeerJ. Computer science1 mentions
  76. 2025Chemical Composition and Anti-Lung Cancer Activities of Melaleuca quinquenervia Leaf Essential Oil: Integrating Gas Chromatography-Mass Spectrometry (GC/MS) Profiling, Network Pharmacology, and Molecular Docking.Pharmaceuticals (Basel, Switzerland)1 mentions
  77. 2025Synthesis and Evaluation of Novel Bis-Chalcone Derivatives Containing a Thiophene Moiety as Potential Anticancer Agents: In Vitro, In Silico , and Mechanistic Studies.ACS omega1 mentions
  78. 2025AI-driven genetic algorithm-optimized lung segmentation for precision in early lung cancer diagnosis.Scientific reports1 mentions
  79. 2025Exploring QSPR in breast cancer drugs via entire neighborhood indices and regression models.Scientific reports1 mentions
  80. 2025Chnoospora minima Polysaccharide-Mediated Green Synthesis of Silver Nanoparticles: Potent Anticancer and Antimicrobial Activities.Biology1 mentions
  81. 2025The Role of Plant-Derived Natural Products as a Regulator of the Tyrosine Kinase Pathway in the Management of Lung Cancer.Current issues in molecular biology1 mentions
  82. 2025Isolation, characterization, and biomedical potential of phycoerythrin phycobiliprotein from Kappaphycus alvarezii (Doty) L. M. Liao: antimicrobial, antioxidant, and anticancer activities.Scientific reports1 mentions
  83. 2025Anticancer Molecular Mechanisms of Epigallocatechin Gallate: An Updated Review on Clinical Trials.Food science & nutrition1 mentions
  84. 2025Eugenol: An Insight Into the Anticancer Perspective and Pharmacological Aspects.Food science & nutrition1 mentions
  85. 2025Next-generation nanoformulation: Glycyrrhiza glabra-based chitosan-curcumin MgO/Fe2O3 nanocomposite for targeted lung cancer therapy with dual antioxidant action.Medical oncology (Northwood, London, England)1 mentions
  86. 2025Targeting the Skp2-Cks1 protein-protein interaction: structures, assays, and preclinical inhibitors.European journal of pharmacology1 mentions
  87. 2025Prevalence of Molecular Mutations in Non-Small Cell Lung Cancer and Current Treatment Approaches in the MENA Region: Systematic Review and Expert Opinion.Journal of immunotherapy and precision oncology1 mentions
  88. 2025Integrative proteo-genomic profiling uncovers key biomarkers of lapatinib resistance in HER2-positive breast cancer.British journal of cancer1 mentions
  89. 2025In silico repurposing of FDA-approved drugs against MEK1: structural and dynamic insights into lung cancer therapeutics.Frontiers in pharmacology1 mentions
  90. 2025Thymol and Carvacrol: Molecular Mechanisms, Therapeutic Potential, and Synergy With Conventional Therapies in Cancer Management.Food science & nutrition1 mentions
  91. 2025Ferroptosis-Linked Six-Gene Panel Enables Machine Learning-Assisted Diagnosis and Therapeutic Guidance in Lung Adenocarcinoma.Biology1 mentions
  92. 2025Long-term Survival in Lung Cancer With Brain Metastases and Coronary Artery Stenosis: A Case Report.Journal of the Saudi Heart Association1 mentions
  93. 2025Coumarin/nitrogen-bearing heterocyclic hybrid-loaded electrospun PMMA/PVP nanofibrous scaffolds for accelerating topical wound healing rates: synthesis and in vitro bio-evaluation.RSC advances1 mentions
  94. 2025Thymoquinone Upregulates microRNA-199a-3p and Downregulates COX-2 Expression and PGE2 Production via Deactivation of p38/ERK/JNK-MAPKs and p65/p50-NF-κB Signaling in Human Lung Cancer Cells.Biology1 mentions
  95. 2025MicroRNA-125b-5p Drives MMP-2 Expression via Activation of RAGE-38MAPK-p65/p50NF-κB Axis: A Novel Mechanism in Human Lung Cancer Cells.International journal of molecular sciences1 mentions
  96. 2025Butylated Neuropeptide Antagonist Targeting Hypoxia-Induced GRPR Overexpression in Small Cell Lung Cancer.International journal of molecular sciences1 mentions
  97. 2025Evaluating the Safety and Efficacy of PD-1 Inhibitors in HIV Patients Diagnosed with Lung Cancer: A Systematic Review.Pharmaceuticals (Basel, Switzerland)1 mentions
  98. 2025Potential Role of Tumor-derived MIF in B-Cell Antigen Presentation in Lung Adenocarcinoma: Single-cell and TCGA Analyses.Anticancer research1 mentions
  99. 2025QSAR-guided discovery of novel KRAS inhibitors for lung cancer therapy.Frontiers in bioinformatics1 mentions
  100. 2025Cuproptosis in lung cancer: a nexus of ncRNA regulation, epigenetics, and tumor microenvironment Remodeling.Clinical and experimental medicine1 mentions